Marcel R.M. van den Brink
Marcel R.M. van den Brink[edit | edit source]
Marcel R.M. van den Brink is a prominent physician-scientist known for his contributions to the field of hematology and oncology. He is particularly recognized for his research on hematopoietic stem cell transplantation and graft-versus-host disease (GVHD).
Education and Career[edit | edit source]
Dr. van den Brink received his medical degree from the University of Leiden in the Netherlands. He completed his residency in internal medicine at the Leiden University Medical Center. Following this, he pursued a fellowship in hematology and oncology at the National Institutes of Health (NIH) in the United States.
Currently, Dr. van den Brink is the Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. He is also a Professor of Medicine at Weill Cornell Medical College.
Research Contributions[edit | edit source]
Dr. van den Brink's research focuses on improving the outcomes of hematopoietic stem cell transplantation. His work has significantly advanced the understanding of graft-versus-host disease, a common complication of bone marrow transplantation.
He has published extensively on the role of the immune system in cancer and transplantation. His studies have explored the mechanisms of immune reconstitution and the development of novel strategies to prevent and treat GVHD.
Awards and Honors[edit | edit source]
Dr. van den Brink has received numerous awards for his contributions to medical research. He is a recipient of the American Society of Hematology's Scholar Award and has been recognized by the American Association for Cancer Research.
External Links[edit | edit source]
- [Memorial Sloan Kettering Cancer Center Profile](https://www.mskcc.org/research-areas/labs/marcel-van-den-brink)
- [PubMed Publications](https://pubmed.ncbi.nlm.nih.gov/?term=Marcel+R.M.+van+den+Brink)
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
